Found 11 matching trials
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) PHASE3 This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) PHASE3 This study is being done to find out if tablets containing extended release...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) PHASE1 This is a single-center, randomized, open-label, 3-period, 3-treatment mult...
Show More Location
Multiple Locations
Learn More & Join Trial
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) PHASE2 This study will examine the effect of statin and niacin therapy on carotid ...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE PHASE3 The primary aim is to assess the effects of raising HDL cholesterol (the go...
Show More Location
Clinical Trial Service Unit, University of Oxford
Learn More & Join Trial
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) PHASE3 To evaluate the efficacy and safety of ezetimibe/simvastatin and niacin in ...
Show More Location
Multiple Locations
Learn More & Join Trial
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) PHASE3 This is a 12-week clinical trial in participants with mixed hyperlipidemia ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST PHASE3 The purpose of this study is to compare the effectiveness and safety of dif...
Show More Location
Multiple Locations
Learn More & Join Trial
MK-0524B Lipid Study (MK-0524B-063) PHASE3 This is a 20-week clinical trial in participants with primary hypercholeste...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) PHASE3 The purpose of this 24 week study is to compare the effectiveness and safet...
Show More Location
Multiple Locations
Learn More & Join Trial